ACTIONABILITY KNOWLEDGE REPOSITORY
ACTIONABILITY CURATION INTERFACE
Update History
Condition: Neurofibromatosis Type II
Gene/Gene Panel: NF2
Context: Adult
2022/02/09
Released
2.0.3
Morbidity and mortality from NF2-related tumors
(GroupA)
Management in specialty centers with multidisciplinary teams for comprehensive care (includes hearing preservation and augmentation, appropriate surveillance, and downstream management)
(GroupA)
11CB
Internal system migration associated with MONDO name addition.
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
NF2
⇔
0007039 NEUROFIBROMATOSIS, TYPE II; NF2
Strong Actionability
Strong Actionability
2022/02/09
Released
(Under revision)
2.0.2
Morbidity and mortality from NF2-related tumors
(GroupA)
Management in specialty centers with multidisciplinary teams for comprehensive care (includes hearing preservation and augmentation, appropriate surveillance, and downstream management)
(GroupA)
11CB
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
NF2
⇔
0007039 NEUROFIBROMATOSIS, TYPE II; NF2
Strong Actionability
Strong Actionability
2021/05/05
Released
2.0.2
Morbidity and mortality from NF2-related tumors
(GroupA)
Management in specialty centers with multidisciplinary teams for comprehensive care (includes hearing preservation and augmentation, appropriate surveillance, and downstream management)
(GroupA)
11CB
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
NF2
⇔
0007039 NEUROFIBROMATOSIS, TYPE II; NF2
Strong Actionability
Strong Actionability
2021/05/05
Released
(Under revision)
2.0.1
Morbidity and mortality from NF2-related tumors
(GroupA)
Management in specialty centers with multidisciplinary teams for comprehensive care (includes hearing preservation and augmentation, appropriate surveillance, and downstream management)
(GroupA)
11CB
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
NF2
⇔
0007039 NEUROFIBROMATOSIS, TYPE II; NF2
Strong Actionability
Strong Actionability
2021/05/05
Released
2.0.1
Morbidity and mortality from NF2-related tumors
(GroupA)
Management in specialty centers with multidisciplinary teams for comprehensive care (includes hearing preservation and augmentation, appropriate surveillance, and downstream management)
(GroupA)
11CB
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
NF2
⇔
0007039 NEUROFIBROMATOSIS, TYPE II; NF2
Strong Actionability
Strong Actionability
2021/05/05
Released
(Under revision)
2.0.0
Morbidity and mortality from NF2-related tumors
(GroupA)
Management in specialty centers with multidisciplinary teams for comprehensive care (includes hearing preservation and augmentation, appropriate surveillance, and downstream management)
(GroupA)
11CB
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
NF2
⇔
0007039 NEUROFIBROMATOSIS, TYPE II; NF2
Strong Actionability
Strong Actionability
2021/05/03
Released
2.0.0
Morbidity and mortality from NF2-related tumors
(GroupA)
Management in specialty centers with multidisciplinary teams for comprehensive care (includes hearing preservation and augmentation, appropriate surveillance, and downstream management)
(GroupA)
11CB
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
NF2
⇔
0007039 NEUROFIBROMATOSIS, TYPE II; NF2
Strong Actionability
Strong Actionability
2021/03/30
Released
(Under revision)
1.2.1
Vestibular schwannoma
(GroupA)
MRI/Screening
(GroupA)
10BB
MONDO IDs added, scoring groups unadjusted.
2020/12/23
Released
1.2.1
Vestibular schwannoma
(GroupA)
MRI/Screening
(GroupA)
10BB
MONDO IDs added, scoring groups unadjusted.
2020/02/19
Released
(Under revision)
1.2.0
Vestibular schwannoma
(GroupA)
MRI/Screening
(GroupA)
10BB
Internal system migration associated with Gene-Disease scoring groups upgrades.
2019/10/03
Released
1.2.0
Vestibular schwannoma
(GroupA)
MRI/Screening
(GroupA)
10BB
Internal system migration associated with Gene-Disease scoring groups upgrades.
2019/04/04
Released
1.1.0
Vestibular schwannoma
MRI/Screening
10BB
Internal system migration related to merging adult and pediatric contexts.
2018/11/01
Released
1.0.2
Vestibular schwannoma
MRI/Screening
10BB
Internal system migration related to score text replacement from E to N